文献速递外周动脉疾病

光纤实时形状技术在周围动脉疾病腔内干预中的早期经验:前瞻性单中心研究

Early Experience of Fiber Optic RealShape Technology in Endovascular Interventions for Peripheral Artery Disease: A Prospective Single-Center Study.
PubMed 文献 · J Endovasc Ther · 2026-10-26

该前瞻性单中心研究评估光纤实时形状(FORS)引导周围动脉疾病(PAD)腔内干预的可行性与安全性。22例患者31处病变中,71.0%病变成功通过FORS器械完成穿越且无不良事件。FORS引导导航在PAD干预中可行且安全,未来联合其他减辐技术或可实现无辐射介入环境。

要点

  • FORS引导下22/31处(71.0%)PAD病变成功穿越,无相关不良事件。
  • 病变中位长度48.0 mm(23.0-87.0),51.6%为重度狭窄,32.3%为中度狭窄。
  • 最复杂狭窄病变的FORS引导导航时间、CAK和FT最高。

核心结论

  • FORS引导导航和病变穿越在PAD干预中可行且安全。

研究设计与样本

  • 前瞻性单中心早期经验研究,纳入22例患者共31处PAD病变接受FORS引导干预。

主要发现

  • 22/31处病变(71.0%)在使用FORS器械时成功穿越,无不良事件。
  • 治疗病变中位长度48.0 mm(23.0-87.0)。
  • 最复杂狭窄病变的FORS引导导航时间、CAK和FT最高。

临床怎么用

  • FORS可作为PAD腔内干预中减少透视依赖的导航选择,尤其适用于病变穿越环节。

局限性

  • 单中心小样本早期经验,可行性以病变穿越技术成功为评价指标。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Interventions in peripheral artery disease (PAD) have changed significantly over the past decades. Most centers have adopted an endovascular-first strategy resulting in an increased radiation exposure, especially for the treatment team. Fiber Optic RealShape (FORS) technology uses laser light instead of fluoroscopy to visualize the specially designed guidewire and catheters. The aim of this early experience overview was to evaluate feasibility and safety of FORS-guided navigation for endovascular interventions in PAD. METHODS: This overview presents prospectively collected, single-center data of FORS-guided PAD interventions. Feasibility was evaluated through technical success in crossing stenotic lesion(s) or occlusion(s). Lesion characteristics were also recorded. Safety was assessed by scoring of intraoperative adverse events related to FORS. Secondary assessments included navigation time, and radiation exposure outcomes (cumulative air kerma [CAK], air kerma-area product [KAP], and fluoroscopy time [FT]) during crossing of the culprit lesion. RESULTS: In 22 patients (31 lesions) selected for FORS-guided PAD interventions, 22 of 31 lesions (71.0%) were successfully crossed while using FORS-enabled devices, without adverse events. Median length of the treated lesions was 48.0 mm (23.0-87.0). Sixteen lesions (51.6%) had a severe degree of stenosis and 10 lesions (32.3%) had a moderate degree of stenosis, defined according to the North American Symptomatic Carotid Endarterectomy Trial criteria. Navigation times, CAK, and FT were highest during FORS-guided interventions of most complex stenotic lesions. CONCLUSION: Fiber Optic RealShape-guided navigation and lesion crossing in PAD interventions is feasible and safe. Expansion of the FORS portfolio hypothetically in combination with other radiation-reducing technologies might enable a radiation-free interventional environment in the future.Clinical ImpactFiber Optic RealShape (FORS) represents a novel technology that enables visualization of specially designed endovascular devices by utilizing laser light instead of fluoroscopy. These devices facilitate real-time visualization with three-dimensional features to simplify endovascular navigation without the necessity of using fluoroscopy during navigation. This is the first single-center study that presents an overview of 31 peripheral arterial disease (PAD) lesions (in 22 patients) showing that using FORS guided navigation in PAD interventions is safe and feasible. Ultimately, the use of FORS in combination with other radiation reducing technologies might eventually enable a radiation-free interventional environment in the future.

来源:J Endovasc Ther,查看原文。版权归原作者所有。

引用

  1. Klaassen, Lodema, van Herwaarden, et al. Early Experience of Fiber Optic RealShape Technology in Endovascular Interventions for Peripheral Artery Disease: A Prospective Single-Center Study. J Endovasc Ther. 2026. PMID: 42935093. doi:10.1177/15266028261489173

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。